| Cvs Pharmacy # 03650 | |
| 625 W Martin Luther King Jr Bv, Tampa, Florida 33603 | |
| (813) 232-2925 |
| Name | Cvs Pharmacy # 03650 |
|---|---|
| Organization Name | Holiday Cvs Llc |
| Location | 625 W Martin Luther King Jr Bv, Tampa, Florida 33603 |
| Type | Pharmacy |
| Phone | (813) 232-2925 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Mersana Therapeutics, a platform-based cancer therapeutics company, today announced that it has initiated a Phase 1 clinical trial to study the safety and pharmacokinetics of XMT-1107 in patients with refractory advanced solid tumors. XMT-1107 is a novel anti-angiogenic fumagillin analog that employs Mersana's Fleximer platform. Mersana's XMT-1001, a conjugate of Fleximer and camptothecin, is currently completing a Phase 1 study.
Researchers have for the first time identified the function of olfactory receptors in the human heart muscle, such as are also present in the nose. One of the receptors reacts to fatty acids that occur in the blood, in patients with diabetes significantly above the normal range.
New research led by an academic at the University of East Anglia suggests that insights from behavioural science can help inform the design of road signs to bring about changes in driver behaviour.
It's a frustrating fact that most people would live longer if only they could make small changes: stop smoking, eat better, exercise more, practice safe sex. Health messaging is one important way to change behavior on a large scale, but while a successful campaign can improve millions of lives, a failed one can be an enormous waste of resources.
Apellis Pharmaceuticals, Inc., a leading biotechnology company applying immunotherapy to autoimmune disease, today announced that it has completed a $33M private placement of its Series C Preferred Stock.
› Verified 6 days ago
| NPI Number | 1205933793 |
| Organization Name | HOLIDAY CVS LLC |
| Doing Business As | CVS PHARMACY 03650 |
| Type | Pharmacy |
| Address | 625 W Martin Luther King Jr Blvd, Tampa, FL 33603 |
| Phone Number | 813-232-2925 |
News Archive
Mersana Therapeutics, a platform-based cancer therapeutics company, today announced that it has initiated a Phase 1 clinical trial to study the safety and pharmacokinetics of XMT-1107 in patients with refractory advanced solid tumors. XMT-1107 is a novel anti-angiogenic fumagillin analog that employs Mersana's Fleximer platform. Mersana's XMT-1001, a conjugate of Fleximer and camptothecin, is currently completing a Phase 1 study.
Researchers have for the first time identified the function of olfactory receptors in the human heart muscle, such as are also present in the nose. One of the receptors reacts to fatty acids that occur in the blood, in patients with diabetes significantly above the normal range.
New research led by an academic at the University of East Anglia suggests that insights from behavioural science can help inform the design of road signs to bring about changes in driver behaviour.
It's a frustrating fact that most people would live longer if only they could make small changes: stop smoking, eat better, exercise more, practice safe sex. Health messaging is one important way to change behavior on a large scale, but while a successful campaign can improve millions of lives, a failed one can be an enormous waste of resources.
Apellis Pharmaceuticals, Inc., a leading biotechnology company applying immunotherapy to autoimmune disease, today announced that it has completed a $33M private placement of its Series C Preferred Stock.
› Verified 6 days ago
News Archive
Mersana Therapeutics, a platform-based cancer therapeutics company, today announced that it has initiated a Phase 1 clinical trial to study the safety and pharmacokinetics of XMT-1107 in patients with refractory advanced solid tumors. XMT-1107 is a novel anti-angiogenic fumagillin analog that employs Mersana's Fleximer platform. Mersana's XMT-1001, a conjugate of Fleximer and camptothecin, is currently completing a Phase 1 study.
Researchers have for the first time identified the function of olfactory receptors in the human heart muscle, such as are also present in the nose. One of the receptors reacts to fatty acids that occur in the blood, in patients with diabetes significantly above the normal range.
New research led by an academic at the University of East Anglia suggests that insights from behavioural science can help inform the design of road signs to bring about changes in driver behaviour.
It's a frustrating fact that most people would live longer if only they could make small changes: stop smoking, eat better, exercise more, practice safe sex. Health messaging is one important way to change behavior on a large scale, but while a successful campaign can improve millions of lives, a failed one can be an enormous waste of resources.
Apellis Pharmaceuticals, Inc., a leading biotechnology company applying immunotherapy to autoimmune disease, today announced that it has completed a $33M private placement of its Series C Preferred Stock.
› Verified 6 days ago
Bay Area Pharmacy & Medical Supply Type: Durable Medical Equipment & Medical Supplies Supplier Location: 10549 N Florida Ave, Tampa, Florida 33612 Phone: (813) 221-3131 | |
Bay Area Pharmacy Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2086 W Busch Blvd, Tampa, Florida 33612 Phone: (813) 234-4200 | |
Apria Healthcare Llc Type: Home Infusion Therapy Pharmacy Location: 5471 W Waters Ave, Tampa, Florida 33634 Phone: (813) 885-5568 | |
Health Aid Co Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4502 N Armenia Ave, Tampa, Florida 33603 Phone: (813) 879-7552 | |
Publix Pharmacy #1324 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 8701 West Hillsborough Ave, Tampa, Florida 33615 Phone: (813) 885-5182 |